These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23842761)

  • 1. Is periprocedural CK-MB a better indicator of prognosis after emergency and elective percutaneous coronary intervention compared with post-procedural cardiac troponins?
    Gollop ND; Dhullipala A; Nagrath N; Myint PK
    Interact Cardiovasc Thorac Surg; 2013 Nov; 17(5):867-71. PubMed ID: 23842761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Periprocedural Myocardial Biomarker Elevation on Mortality Following Elective Percutaneous Coronary Intervention.
    Garcia-Garcia HM; McFadden EP; von Birgelen C; Rademaker-Havinga T; Spitzer E; Kleiman NS; Cohen DJ; Kennedy KF; Camenzind E; Mauri L; Steg PG; Wijns W; Silber S; van Es GA; Serruys PW; Windecker S; Cutlip D; Vranckx P
    JACC Cardiovasc Interv; 2019 Oct; 12(19):1954-1962. PubMed ID: 31601389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognosis of periprocedural myocardial infarction after percutaneous coronary interventions.
    Zimarino M; Affinito V
    Cardiovasc Revasc Med; 2013; 14(1):32-6. PubMed ID: 23164601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of creatine kinase-myocardial band isoenzyme elevation following percutaneous coronary intervention: a meta-analysis.
    Jang JS; Jin HY; Seo JS; Yang TH; Kim DK; Kim DS; Cho KI; Kim BH; Je HG; Park YH
    Catheter Cardiovasc Interv; 2013 May; 81(6):959-67. PubMed ID: 22744792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periprocedural myocardial injury in chronic total occlusion percutaneous interventions: a systematic cardiac biomarker evaluation study.
    Lo N; Michael TT; Moin D; Patel VG; Alomar M; Papayannis A; Cipher D; Abdullah SM; Banerjee S; Brilakis ES
    JACC Cardiovasc Interv; 2014 Jan; 7(1):47-54. PubMed ID: 24332422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker release after percutaneous coronary intervention in patients without established myocardial infarction as assessed by cardiac magnetic resonance with late gadolinium enhancement.
    Vieira de Melo RM; Hueb W; Nomura CH; Ribeiro da Silva EE; Villa AV; Oikawa FTC; da Costa LMA; Rezende PC; Garzillo CL; Lima EG; Franchini Ramires JA; Kalil Filho R
    Catheter Cardiovasc Interv; 2017 Jul; 90(1):87-93. PubMed ID: 28573785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative prognostic value of postprocedural creatine kinase myocardial band and high-sensitivity troponin T in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Ndrepepa G; Colleran R; Braun S; Xhepa E; Hieber J; Cassese S; Fusaro M; Kufner S; Laugwitz KL; Schunkert H; Kastrati A
    Catheter Cardiovasc Interv; 2018 Feb; 91(2):215-223. PubMed ID: 28500730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality.
    Kini AS; Lee P; Marmur JD; Agarwal A; Duffy ME; Kim MC; Sharma SK
    Am J Cardiol; 2004 Jan; 93(1):18-23. PubMed ID: 14697460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of baseline C-reactive protein levels with periprocedural myocardial injury in patients undergoing percutaneous bifurcation intervention: a CACTUS study subanalysis.
    Niccoli G; Sgueglia GA; Latib A; Crea F; Colombo A;
    Catheter Cardiovasc Interv; 2014 Jan; 83(1):E37-44. PubMed ID: 23813627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, correlates, and significance of abnormal cardiac enzyme rises in patients treated with surgical or percutaneous based revascularisation: a substudy from the Synergy between Percutaneous Coronary Interventions with Taxus and Cardiac Surgery (SYNTAX) Trial.
    Farooq V; Serruys PW; Vranckx P; Bourantas CV; Girasis C; Holmes DR; Kappetein AP; Mack M; Feldman T; Morice MC; Colombo A; Morel MA; de Vries T; Dawkins KD; Mohr FW; James S; Ståhle E
    Int J Cardiol; 2013 Oct; 168(6):5287-92. PubMed ID: 23993326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations between cardiac troponin I, cardiac troponin T, and creatine phosphokinase MB elevation following successful percutaneous coronary intervention and prognostic value of each marker.
    Okmen E; Kasikcioglu H; Sanli A; Uyarel H; Cam N
    J Invasive Cardiol; 2005 Feb; 17(2):63-7. PubMed ID: 15687525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Periprocedural Myocardial Injury and Infarction Definitions on Long-Term Mortality After Chronic Total Occlusion Percutaneous Coronary Intervention.
    Song L; Wang Y; Guan C; Zou T; Sun Z; Xie L; Zhang R; Dou K; Yang W; Wu Y; Qiao S; Xu B
    Circ Cardiovasc Interv; 2021 Nov; 14(11):e010923. PubMed ID: 34674557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optical coherence tomography-based predictors for creatine kinase-myocardial band elevation after elective percutaneous coronary intervention for in-stent restenosis.
    Lee SY; Hong MK; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y
    Catheter Cardiovasc Interv; 2015 Mar; 85(4):564-72. PubMed ID: 25158217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention.
    Nageh T; Sherwood RA; Harris BM; Byrne JA; Thomas MR
    Int J Cardiol; 2003 Dec; 92(2-3):285-93. PubMed ID: 14659867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and impact on prognosis of peri-procedural myocardial infarction in 2760 elective patients with stable angina pectoris in a historical prospective follow-up study.
    Christensen MK; Huang H; Torp-Pedersen C; Trydal T; Ravkilde J
    BMC Cardiovasc Disord; 2016 Jun; 16():140. PubMed ID: 27305902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of crossing technique on the incidence of periprocedural myocardial infarction during chronic total occlusion percutaneous coronary intervention.
    Stetler J; Karatasakis A; Christakopoulos GE; Tarar MN; Amsavelu S; Patel K; Rangan BV; Roesle M; Resendes E; Grodin J; Abdullah S; Banerjee S; Brilakis ES
    Catheter Cardiovasc Interv; 2016 Jul; 88(1):1-6. PubMed ID: 27014962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. With the "universal definition," measurement of creatine kinase-myocardial band rather than troponin allows more accurate diagnosis of periprocedural necrosis and infarction after coronary intervention.
    Lim CC; van Gaal WJ; Testa L; Cuculi F; Arnold JR; Karamitsos T; Francis JM; Petersen SE; Digby JE; Westaby S; Antoniades C; Kharbanda RK; Burrell LM; Neubauer S; Banning AP
    J Am Coll Cardiol; 2011 Feb; 57(6):653-61. PubMed ID: 21292125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reporting.
    Vranckx P; Farooq V; Garg S; Van Es GA; Silber S; Windecker S; Stone GW; Serruys PW
    Heart; 2012 Oct; 98(19):1424-30. PubMed ID: 22821273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal elevation of myocardial necrosis biomarkers after coronary artery bypass grafting without established myocardial infarction assessed by cardiac magnetic resonance.
    Oikawa FTC; Hueb W; Nomura CH; Hueb AC; Villa AV; da Costa LMA; de Melo RMV; Rezende PC; Segre CAW; Garzillo CL; Lima EG; Ramires JAF; Filho RK
    J Cardiothorac Surg; 2017 Dec; 12(1):122. PubMed ID: 29284532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of clopidogrel in the reduction of myocardial damage during percutaneous coronary intervention.
    Dasgupta A; Mukherjee D
    Vasc Health Risk Manag; 2009; 5(1):275-86. PubMed ID: 19436675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.